Anti-Complement C5 Antibody (Pozelimab)
Catalog No.
F1354
Anti-Complement C5 Antibody (Pozelimab)
Featured Products
Pozelimab (REGN3918) is a human IgG4 anti-component 5 C5 monoclonal antibody. Pozelimab binds C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used in the study of complement-mediated diseases.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2096328-94-6
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
REGN3918
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01031
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Complement C5
Please avoid freeze-thaw cycles.